Valvular heart disease affects 2.5% of the U.S. population and 13% of those aged 80 and over. Early identification can significantly improve life quality through treatments that halt disease progression. In a paper published in The Lancet, researchers shed light on current and future technologies that could soon help doctors reduce the number of Americans who die each year from valvular disease (roughly 25,000)